Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of Leptospira spp.: homology modeling, docking, and molecular dynamics study

Leptospira interrogans, a Gram-negative bacterial pathogen is the main cause of human leptospirosis. Lipid A is a highly immunoreactive endotoxic center of lipopolysaccharide (LPS) that anchors LPS into the outer membrane of Leptospira. Discovery of compounds inhibiting lipid-A biosynthetic pathway would be promising for dissolving the structural integrity of membrane leading to cell lysis and death of Leptospira. LpxC, a unique enzyme of lipid-A biosynthetic pathway was identified as common drug target of Leptospira. Herein, homology modeling, docking, and molecular dynamics (MD) simulations were employed to discover potential inhibitors of LpxC. A reliable tertiary structure of LpxC in complex with inhibitor BB-78485 was constructed in Modeller 9v8. A data-set of BB-78485 structural analogs were docked with LpxC in Maestro v9.2 virtual screening workflow, which implements three stage Glide docking protocol. Twelve lead molecules with better XP Gscore compared to BB-78485 were proposed as potential inhibitors of LpxC. Para-(benzoyl)-phenylalanine – that showed lowest XP Gscore (−10.35 kcal/mol) – was predicted to have best binding affinity towards LpxC. MD simulations were performed for LpxC and para-(benzoyl)-phenylalanine docking complex in Desmond v3.0. Trajectory analysis showed the docking complex and inter-molecular interactions was stable throughout the entire production part of MD simulations. The results indicate para-(benzoyl)-phenylalanine as a potent drug molecule against leptospirosis. An animated Interactive 3D Complement (I3DC) is available in Proteopedia at http://proteopedia.org/w/Journal:JBSD:10

[1]  蔡季重,et al.  Leptospirosis , 1938, The Indian medical gazette.

[2]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[3]  I. Azuma,et al.  Identification of 4‐O‐Methylmannose in Cell Wall Polysaccharide of Leptospira , 1983, Microbiology and immunology.

[4]  B. Adler,et al.  Characterization and taxonomic significance of lipopolysaccharides of Leptospira interrogans serovar hardjo. , 1989, Journal of general microbiology.

[5]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[6]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[7]  A. Patchett,et al.  Antibacterial Agents That Inhibit Lipid A Biosynthesis , 1996, Science.

[8]  Gapped BLAST and PSI-BLAST: A new , 1997 .

[9]  J. Thompson,et al.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.

[10]  W. L. Jorgensen,et al.  Prediction of Properties from Simulations: Free Energies of Solvation in Hexadecane, Octanol, and Water , 2000 .

[11]  O. Dym,et al.  Sequence‐structure analysis of FAD‐containing proteins , 2001, Protein science : a publication of the Protein Society.

[12]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[13]  W. L. Jorgensen,et al.  Prediction of drug solubility from structure. , 2002, Advanced drug delivery reviews.

[14]  S. Chandler,et al.  Antibacterial Activities and Characterization of Novel Inhibitors of LpxC , 2002, Antimicrobial Agents and Chemotherapy.

[15]  C. Whitfield,et al.  Lipopolysaccharide endotoxins. , 2002, Annual review of biochemistry.

[16]  M. Congreve,et al.  A 'rule of three' for fragment-based lead discovery? , 2003, Drug discovery today.

[17]  A. Danchin,et al.  Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing , 2003, Nature.

[18]  A. Elofsson,et al.  Can correct protein models be identified? , 2003, Protein science : a publication of the Protein Society.

[19]  M. Willig,et al.  Leptospirosis: a zoonotic disease of global importance. , 2003, The Lancet. Infectious diseases.

[20]  Marcin von Grotthuss,et al.  Ligand-Info, Searching for Similar Small Compounds Using Index Profiles , 2003, Bioinform..

[21]  J. Setubal,et al.  Genome features of Leptospira interrogans serovar Copenhageni. , 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[22]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[23]  G. Trueba,et al.  Cell aggregation: a mechanism of pathogenic Leptospira to survive in fresh water. , 2004, International microbiology : the official journal of the Spanish Society for Microbiology.

[24]  J. Bajorath,et al.  Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.

[25]  A. Hopkins,et al.  Navigating chemical space for biology and medicine , 2004, Nature.

[26]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[27]  D. Fitzgerald,et al.  The productive conformation of prostaglandin G2 at the peroxidase site of prostaglandin endoperoxide H synthase: docking, molecular dynamics, and site-directed mutagenesis studies. , 2006, Biochemistry.

[28]  J. An,et al.  Structure-based virtual screening of chemical libraries for drug discovery. , 2006, Current opinion in chemical biology.

[29]  Matthew P. Repasky,et al.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.

[30]  Anna Tramontano,et al.  The PMDB Protein Model Database , 2005, Nucleic Acids Res..

[31]  R. Coppel,et al.  Genome reduction in Leptospira borgpetersenii reflects limited transmission potential , 2006, Proceedings of the National Academy of Sciences.

[32]  C. Médigue,et al.  A Genomic Island of the Pathogen Leptospira interrogans Serovar Lai Can Excise from Its Chromosome , 2006, Infection and Immunity.

[33]  A. Węgrzyn,et al.  Leptospirosis vaccines , 2007, Microbial cell factories.

[34]  Manfred J. Sippl,et al.  Thirty years of environmental health research--and growing. , 1996, Nucleic Acids Res..

[35]  Jeremy R. Greenwood,et al.  Epik: a software program for pKa prediction and protonation state generation for drug-like molecules , 2007, J. Comput. Aided Mol. Des..

[36]  Kenyon G. Daniel,et al.  Computational Validation of the Importance of Absolute Stereochemistry in Virtual Screening , 2008, J. Chem. Inf. Model..

[37]  Structure and Function of Sedoheptulose-7-phosphate Isomerase, a Critical Enzyme for Lipopolysaccharide , 2008 .

[38]  Narayanan Eswar,et al.  Protein structure modeling with MODELLER. , 2008, Methods in molecular biology.

[39]  I. Mochalkin,et al.  Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB‐78485 inhibitor , 2008, Protein science : a publication of the Protein Society.

[40]  Dibyabhaba Pradhan,et al.  In silico approach for future development of subunit vaccines against Leptospira interrogans serovar Lai , 2009 .

[41]  Jeffrey J. Gray,et al.  Toward high‐resolution homology modeling of antibody Fv regions and application to antibody–antigen docking , 2009, Proteins.

[42]  C. Bertozzi,et al.  Uridine-based inhibitors as new leads for antibiotics targeting Escherichia coli LpxC. , 2009, Biochemistry.

[43]  A. Ko,et al.  Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen , 2009, Nature Reviews Microbiology.

[44]  S. Yoshida,et al.  In Vitro Sensitivity and Resistance of 46 Leptospira Strains Isolated from Rats in the Philippines to 14 Antimicrobial Agents , 2010, Antimicrobial Agents and Chemotherapy.

[45]  E. Moriyama,et al.  Evolution of the Kdo2-lipid A biosynthesis in bacteria , 2010, BMC Evolutionary Biology.

[46]  Jaakko Akola,et al.  Steered molecular dynamics simulations of ligand–receptor interaction in lipocalins , 2011, European Biophysics Journal.

[47]  Dibyabhaba Pradhan,et al.  Virtual screening for potential inhibitors of homology modeled Leptospira interrogans MurD ligase , 2010, Journal of chemical biology.

[48]  B. Adler,et al.  Leptospira and Leptospirosis , 2001, Current Topics in Microbiology and Immunology.

[49]  Dibyabhaba Pradhan,et al.  Identification of Potential Leptospira Phosphoheptose Isomerase Inhibitors Through Virtual High-Throughput Screening , 2010, Genom. Proteom. Bioinform..

[50]  U. Amineni,et al.  In silico identification of common putative drug targets in Leptospira interrogans , 2010, Journal of chemical biology.

[51]  E. Denes,et al.  Leptospirosis: An Unusual Cause of ARDS , 2010, Critical care research and practice.

[52]  Eric T. Kim,et al.  How does a drug molecule find its target binding site? , 2011, Journal of the American Chemical Society.

[53]  Zesheng Li,et al.  Molecular dynamics studies of the 3D structure and planar ligand binding of a quadruplex dimer , 2011, Journal of molecular modeling.

[54]  Georgios Archontis,et al.  Kinetics, in silico docking, molecular dynamics, and MM‐GBSA binding studies on prototype indirubins, KT5720, and staurosporine as phosphorylase kinase ATP‐binding site inhibitors: The role of water molecules examined , 2011, Proteins.

[55]  F. Tanaka,et al.  Homology modelling and molecular dynamics simulations of wild type and mutated flavodoxins from Desulfovibrio vulgaris (Miyazaki F): insight into FMN–apoprotein interactions , 2011 .

[56]  Santiago Vilar,et al.  In silico analysis of the binding of agonists and blockers to the β2-adrenergic receptor. , 2011, Journal of molecular graphics & modelling.

[57]  B. Hirschel,et al.  Severe Leptospirosis with Multiple Organ Failure Successfully Treated by Plasma Exchange and High-Volume Hemofiltration , 2011, Case reports in nephrology.

[58]  A. Tyagi,et al.  Molecular modeling studies of Fatty acyl-CoA synthetase (FadD13) from Mycobacterium tuberculosis—a potential target for the development of antitubercular drugs , 2011, Journal of molecular modeling.

[59]  Zhihua Lin,et al.  Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus , 2011, Journal of molecular modeling.

[60]  Dibyabhaba Pradhan,et al.  Computer aided subunit vaccine design against pathogenic Leptospira serovars , 2012, Interdisciplinary Sciences: Computational Life Sciences.